Sign in

CIK 0001701541 · Non-accelerated filer<br>Smaller reporting company

Black Diamond Therapeutics, Inc.

Sign in to watch
Ticker
BDTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
814254660
Phone
617-417-5868
Business address
245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
Former names
Aset Therapeutics, Inc.
  1. SC 13D/A Stake Beneficial Ownership Report
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. ARS Other Annual Report to Security Holders
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. PRE 14A Proxy Proxy Statement (Preliminary)
  13. 8-K Event Executive or director change · Regulation FD disclosure
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 4 Insider Changes in Ownership

Page 7 of 25 · 487 filings